At a glance
- Originator Wyeth
- Class Anti-ischaemics; Antiarrhythmics; Heart failure therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 20 Mar 1997 No-Development-Reported for Arrhythmias in USA (Unknown route)